Nuvalent Correlations
NUVL Stock | USD 76.66 0.36 0.47% |
The current 90-days correlation between Nuvalent and Arcellx is 0.38 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nuvalent moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nuvalent moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Nuvalent Correlation With Market
Modest diversification
The correlation between Nuvalent and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and DJI in the same portfolio, assuming nothing else is changed.
Nuvalent |
Moving together with Nuvalent Stock
0.69 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.84 | DNLI | Denali Therapeutics | PairCorr |
0.61 | VCEL | Vericel Corp Ord | PairCorr |
0.73 | VCYT | Veracyte | PairCorr |
0.71 | VERA | Vera Therapeutics | PairCorr |
0.62 | VKTX | Viking Therapeutics | PairCorr |
0.67 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.69 | VRDN | Viridian Therapeutics Downward Rally | PairCorr |
0.62 | VTRS | Viatris | PairCorr |
0.66 | VTYX | Ventyx Biosciences | PairCorr |
Moving against Nuvalent Stock
0.47 | DVAX | Dynavax Technologies | PairCorr |
0.4 | VALN | Valneva SE ADR | PairCorr |
0.52 | VRNA | Verona Pharma PLC | PairCorr |
0.4 | VSTM | Verastem | PairCorr |
0.34 | EDSA | Edesa Biotech | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Nuvalent Stock performing well and Nuvalent Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nuvalent's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DICE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ACLX | 2.36 | (0.10) | 0.00 | (0.23) | 0.00 | 4.95 | 13.77 | |||
PCVX | 2.24 | (0.16) | 0.00 | (0.22) | 0.00 | 3.86 | 19.90 | |||
VRDN | 2.90 | (0.16) | 0.00 | (0.29) | 0.00 | 4.61 | 29.75 | |||
VTYX | 3.63 | (1.09) | 0.00 | (17.50) | 0.00 | 6.88 | 27.07 | |||
CGEM | 2.57 | (0.41) | 0.00 | (0.68) | 0.00 | 5.13 | 15.27 | |||
KNSA | 1.82 | 0.18 | 0.08 | 0.27 | 2.68 | 3.64 | 10.97 | |||
REPL | 2.82 | 0.09 | 0.00 | (0.03) | 0.00 | 5.86 | 22.75 | |||
ASND | 2.54 | 0.51 | 0.20 | 0.39 | 2.22 | 5.86 | 18.15 |
Nuvalent Corporate Management
Darlene Noci | Chief Officer | Profile | |
Matthew MBA | Senior Resources | Profile | |
Perrin BS | Senior Strategy | Profile | |
Prof Shair | Head Founder | Profile | |
John Soglia | Senior Development | Profile | |
Christopher MD | Chief Officer | Profile |